Dendritic cells (DCs) as a rare type of leukocytes play an important role in bridging the innate and adaptive immune system. A subset of DCs, monocyte-derived dendritic cells (moDCs), exists in very low numbers at steady state but become abundant in inflammatory states. These inflammation-associated DCs are potent producers of pro-inflammatory cytokines and potent inducers of T helper differentiation. They behave as a "double-edge" sword so that they not only mediate protective immunity but also immuno-pathology. It is still incompletely understood how their function is regulated. Emerging evidence indicates that microRNAs (miRNAs), as a new class of gene regulators, potently regulate the function of moDCs. Here we summarize recent progress in this area.
Discovery of dendritic cells (DCs) in the early 1970s by the late Noble laureate Ralph Steinman (Steinman and Cohn, 1973) represents a great milestone of modern immunology. Continuous efforts over more than four decades have enhanced immensely our understanding of how DCs as professional antigen-presenting cells shape the adaptive immune response. As a whole, DCs can respond to various self and non-self antigens presented in environment and induce vastly different types of adaptive immune responses. To a large degree, DCs fulfil the vast different tasks by a division of labour among ever-growing members of the DC family (Shortman and Naik, 2007) .
Mouse DCs can be grouped into lymphoid tissue-resident DCs, migratory DCs (also called non-lymphoid resident DC) and moDCs. Lymphoid tissue-resident DCs comprise three subsets of conventional DCs (CD8 + , CD4
+ and CD4 -CD8 -DCs) and plasmacytoid DCs (pDCs). CD8 + DCs are very proficient in producing IL-12 , in engulfing cellular antigen (Iyoda et al., 2002) and in presenting exogenously derived antigen into the MHC class I pathway (cross-presentation) (den Haan et al., 2000) , and in the uptake of Listeria monocytogenes (Neuenhahn et al., 2006; Edelson et al., 2011; Zhan et al., 2011) . pDCs are functionally potent IFN-α-producers (Asselin-Paturel et al., 2001; Nakano et al., 2001; O'Keeffe et al., 2002 (Poulin et al., 2007; Merad et al., 2008; King et al., 2010) . Gut and gut-associated lymphoid tissues also contain CD11b + CD103 + cells (Bogunovic et al., 2009; Varol et al., 2009 ). These migratory DC subsets also have quite unique functions (Kaplan et al., 2005; Bedoui et al., 2009; King et al., 2010; Lewis et al., 2011; Shklovskaya et al., 2011) . DCs represent a rare type of leukocyte in lymphoid tissues. Nevertheless, the above subsets of lymphoid tissue-resident DCs and migratory DCs are relatively abundant under the steady state. On the other hand, numbers of moDCs in lymphoid tissue are very low at steady state. However, in inflammatory states (in the presence of infection with bacteria, virus or parasites), moDCs becomes a major DC type. They differentiate from recruited monocytes after upregulating © Higher Education Press and Springer-Verlag Berlin Heidelberg 2012 CD11c and MHC class II molecules (Serbina et al., 2003) . The moDCs also express CCR2, Ly6c and Mac-3 that can distinguish them from resident CD11b + (CD4 + and CD4 -) DCs. Recruitment of monocytes (moDC precursors) into inflammatory sites is largely dependent on CCR2 (Serbina and Pamer, 2006) . Functionally, moDCs are major producers of pro-inflammatory cytokines (Serbina et al., 2003; Xu et al., 2007; Zhan et al., 2010) , inducers of Th1 differentiation (Leon et al., 2007) and memory T cell activation (Wakim et al., 2008) , and antigen cross-presenting cells (Cheong et al., 2010) . By exhibiting these potent functions, moDCs offer a protective immunity role as well as mediate immunopathology (Aldridge et al., 2009) . In autoimmune inflammation, moDCs are likely to be the major mediators of pathology (Campbell et al., 2011) .
MoDCs are one of the differentiation fates for monocytes as monocytes can also differentiate into many other types of tissue dendritic cells such as Langerhans cells and mucosal DCs (see a detailed review by Dominguez and Ardavin (2010) ). Like other dendritic cells, moDCs seem also to contain subsets. Inflammatory moDCs that become abundant in acute infection are comprised of mainly Ly6c
Under some TLR stimulation, Ly6c -/low moDCs can be induced (Cheong et al., 2010) . GM-CSF has been commonly used to differentiate human and mouse DCs from monocytes and BM cells in vitro (Inaba et al., 1992; Reid et al., 1992; Santiago-Schwarz et al., 1993) . With increasing knowledge of the presence of in vivo DC subsets, a question is which in vivo DC subset resembles the DCs generated in vitro in the presence of GM-CSF. By direct comparison of expression of surface markers and functions, it has been suggested that in vitro GM-CSF-differentiated DCs are the equivalents of in vivo moDCs that are capable of producing large quantities of TNF-α and inducible nitric oxide (NO) synthase emerging after infection (Xu et al., 2007) . Despite that GM-CSF is a potent cytokine differentiating DCs from monocytes, how critical GM-CSF is for in vivo differentiation of moDCs is less clear. At least, in some mouse models, GM-CSF is believed to positively regulate the in vivo production of moDCs (Naik et al., 2006; Campbell et al., 2011) . However, in response to acute infection like systemic infection with Listeria monocytogenes, recruitment /maturation of Ly6c + moDCs was not obviously hampered in the Gm-csf -/-mice (Zhan et al., 2012) . (Aliberti et al., 2003; Edelson et al., 2010; Jackson, 2011; Sathe and Wu, 2011) , while IRF-4 on the other hand, is critical for differentiation of CD8 -cDC (Geissmann et al., 2010) . PU.1 also exhibits differential effect on Fl3t-L-induced or GM-CSF induced DC differentiation (Carotta et al., 2010) . Although these transcription factors control differentially the generation of DC subsets, it is less clear whether they have a direct role in regulating DC function. A member of NFκB family, c-Rel is thought to control IL-12p35 production by CD8 + cDCs (Grumont et al., 2001) .
REGULATION OF FUNCTIONAL SPECIALIZATION OF DC SUBSETS
Despite the general importance of the NFκB family in cell activation including activation of DCs, how DC subsets utilize individual members of the NFκB family to control their function is less clear. Regulation of gene expression in DCs does not necessarily involve a change in DNA sequence. For example, regulation of IL-12 production in DCs has been shown to be associated with an epigenetic mechanism of gene regulation by histone methylation (Wen et al., 2008) . Within the past several years a new model of gene regulation has emerged that involves control of gene expression exerted by small non-coding RNAs (microRNAs, miRNAs). Such mechanism of gene regulation is increasingly recognized to play a critical role in regulating differentiation and function of DCs and DC subsets.
MicroRNAs AS A NEW CLASS OF GENE REGULATORS
MicroRNAs (miRNAs) belong to small regulatory non-coding RNAs to repress target transcripts post-transcriptionally. They are of ~22 nucleotides (nt) in their mature forms. Canonical miRNAs are initially transcribed as long primary transcripts (pri-miRNAs) bearing one or more miRNA hairpins. The pri-miRNAs are processed into a precursor miRNA (pre-miRNA) stem-loop of ~60 nt in length by the nuclear RNase III enzyme Drosha and its partner DiGeorge syndrome critical region gene 8 (DGCR8). Pre-miRNAs are then transported into the cytosol by Exportin-5 and further processed by the Dicer RNase III enzyme into mature, 22 nt-long double strand miRNAs. Multiple mechanisms have been described for miRNA-mediated gene silencing. In general, the RNA-induced silencing complex (RISC) containing the Argonaute (AGO) proteins act as core components. miRNAs typically contain several mismatches when paired with target mRNAs, causing translational repression and mRNA cleavage/degradation. Each miRNA is predicted to target multiple mRNAs while several miRNAs can also regulate one mRNA. Moreover, miRNA could also target transcription factors, adding much more complexity to their regulatory function (Xiao and Rajewsky, 2009) . miRNAs constitute one of the largest gene families with over 700 members in mouse and 1000 in humans. Within hematopoietic cells, miRNAs are differentially expressed by different lineages of hematopoietic cells (Chen et al., 2004) . Within DC lineages, the miRNA expression pattern is also unique between DC subsets (Kuipers et al., 2010a) . For the same type of DCs, expression of miRNAs can also change during activation (Ceppi et al., 2009; Sun et al., 2011) .
Importance of miRNAs in control of differentiation and function of hematopoietic cells is clearly evident from studies that genetic disrupt critical enzymes important for the biosynthesis of miRNAs. By gene targeting, it has been shown that genetic deficiency of Drosha results in the loss of mature miRNAs (Chong et al., 2008) . In hematopoietic cells, T cell-specific Drosha as well as Dicer conditional knockout mice both spontaneously develop lymphoproliferative multi-organ inflammatory disease and die within a few weeks of birth, again indicating that importance of the two enzymes in leukocyte differentiation and function (Chong et al., 2008) . In DCs, lineage-specific (CD11c + ) deletion of Dicer caused reduction in langerhans cells without obvious perturbation of other subsets (Kuipers et al., 2010b) . Lack of DC phenotypes is proposed to be due to the short life span of resident DCs and long half-life of miRNAs (Kuipers et al., 2010b) , it could also be that deletion of Dicer in CD11c + cells is too late to affect DC differentiation from CD11c -precursors. Nevertheless, in vitro manipulation of miRNA expression in DC precursors can change development fate of normal DCs (Kuipers et al., 2010a) . We also found that blocking biosynthesis of miRNAs in DC precursors with inducible deletion of Drosha perturbed DC differentiation in vitro and in vivo (YZ, unpublished data). Even removal of an individual miRNA profoundly perturbs development and function of immune cells including DCs (Rodriguez et al., 2007; Xiao et al., 2007) . Taken together, miRNAs likely play some roles in regulating DC development (Turner et al., 2011) . As DC homeostasis is controlled by cell survival/death, proliferation, migration, maturation as well as bona fide differentiation, how miRNAs contribute to DC homeostasis is yet to be unravelled. Thorough and systemic analyses of expression of miRNAs by DCs and DC subsets, particularly DC subsets present in vivo, have not been reported. Individual miRNAs are therefore selected for functional evaluation based on limited expression data. Most of the current information available on the influence of miRNAs on DCs is from in vitro studies with GM-CSF differentiated DCs. We believe that these studies collectively provide a lead as to how miRNAs might regulate DC function and ultimately immune response to self and non-self antigens. In the following sessions we summarize the progress made recently in the field, particularly the studies on the roles of miRNAs in several aspects of moDC function.
miRNAs REGULATE CYTOKINE PRODUCTION BY moDCs
Although all DCs are capable of producing cytokines in response to TLR and non-TLR stimulation, moDCs are particularly potent producers of pro-inflammatory cytokines (Xu et al., 2007) . When different DC subsets were isolated from Listeria monocytogene-infected mice, moDCs were the dominant DC type to produce many pro-inflammatory cytokines (YZ, unpublished data). These cytokines critically shape T cell differentiation into different lineages with unique functions. For example, IL-1, IL-6 and IL-23 are critical for induction/maintenance of a Th17 response (Stockinger and Veldhoen, 2007) while IL-12 is critical for induction of a Th1 response (Hsieh et al., 1993) . Currently, how cytokine production by moDCs is regulated and how these will shape the adaptive immune response is still incompletely understood. Evidence that we have summarised below provides how miRNAs are involved in the regulation of cytokine production by moDCs. As individual miRNAs can have effect on multiple cytokines (as well as non-cytokine targets) and an individual cytokine can be subjected to positive and negative regulation by multiple miRNAs, here we have centred on the effect of different miRNAs on one particular cytokine.
IL-1
When human moDCs were stimulated with LPS, miR155 among several other miRNAs was highly up-regulated (Ceppi et al., 2009) . Silencing miR-155 resulted in enhanced gene activation related to IL-1 production. Other up-regulated inflammatory cytokines that were associated with miR-155 silence included IL-6, TNF-α and IL-23 (Ceppi et al., 2009) . The data suggest that miR-155 negatively regulates production of inflammatory cytokines. In search of the direct targets of miR-155, TAB2, an adaptor in TLR/IL-1 signaling cascade, was identified as a direct target (Ceppi et al., 2009 ).
IL-6
miR-155 acts as a negative regulator of production of IL-1 also regulates IL-6 production by human moDCs during LPS-stimulation (Ceppi et al., 2009 ). However, two subse-© Higher Education Press and Springer-Verlag Berlin Heidelberg 2012 quent studies showed that miR-155 could also act as a positive regulator for production of several pro-inflammatory cytokines including IL-6, IL-23, IL-12 and TNF-α by LPS-stimulated in vitro derived mouse moDCs (O'Connell et al., 2010; Dunand-Sauthier et al., 2011) . The modulation of cytokine production by miR-155 is explained by miR-155 targeting negative regulators of signalling: SOCS1 and SHIP1 (O'Connell et al., 2009; Lu, 2009 ). However, whether moDCs utilize miR-155 to target these negative regulators has not been examined. Apart from different sources of moDCs (human vs mouse), it remains to reconcile the contradictory findings regarding the role of miR-155 in regulating the production of proinflammatory cytokines by moDCs.
miR-142-3p was also identified as a key negative regulator of IL-6 (Sun et al., 2011) . Differing from miR-155 that is strongly up-regulated after LPS stimulation, miR-142-3p is constitutively and highly expressed in resting moDCs but down-regulated after LPS stimulation (Sun et al., 2011) . Also differing from miR-155 which targets upstream signaling of cytokine induction, miR-142-3p directly targets IL-6 mRNA and thus specifically affects IL-6 expression (Sun et al., 2011) . In addition to the above two miRNAs that modulate IL-6 production by LPS-stimulated moDCs, miR-148/152 were also found to suppress IL-6 production by in vitro-derived moDCs via targeting calcium/calmodulin-dependent protein kinase II .
IL-10
As an anti-inflammatory cytokine, IL-10 is also subjected to regulation by miRNA (Sharma et al., 2009) . In human Jurkat cell line, mIR-106a has been demonstrated to regulate IL-10 expression (Sharma et al., 2009) . In macrophages, miR-466I and miR-98 are also implicated in regulation of IL-10. A recent study showed that mouse and human moDCs that were tranfected with miR-23b had increased IL-10 production when they were pulsed with ovalbumin (OVA) (Zheng et al., 2012) . It is not clear from the study whether/how OVA or potentially contaminants including LPS actually stimulates moDCs. The study suggests that miR-23b causes inhibition of Notch1 and NFκB (Zheng et al., 2012) .
IL-12
Several miRNAs had been reported to modulate IL-12 production. miR-21 was initially identified to inhibit IL-12p35 in a reporter system (Lu et al., 2009b) . Furthermore, mutating miR-21 binding sites in IL-12p35 3'-untranslated region abrogated miR-21-mediated repression. Thus, IL-12p35 is likely the direct target of miR-21 (Lu et al., 2009b) . These researchers further generated miR-21 deficient mice. Compared to wild type mice, in vitro derived moDCs from these mutant mice had enhanced production of IL-12 but not several other cytokines (including TNF-α, IL-6 and IL-23) when they were stimulated with LPS (with or without IFN-γ) (Lu et al., 2011b) . In vivo, miR-21 deficient mice also generated a stronger antigen-specific Th1 response, although which DCs contributed to Th polarization in vivo was not clear.
Another miRNA, miR-10a, also directly targets the IL-12 gene (Xue et al., 2011) . Unlike miR-21, miR-10a negatively regulates IL-12/IL-23p40. Ectopic expression in moDCs suppressed both production of IL-12 and IL-23 (Xue et al., 2011) . Expression of miR-10a in moDCs was down-regulated by TLR stimulation. The down-regulation perhaps allows production of IL-12 and IL-23. The study also showed that miR-10a expression is high in mucosal innate cells and expression was inhibited by intestinal microbiota (Xue et al., 2011) . However, given the complex composition of mucosal DCs, which DC subset(s) expressing miR-10a was not indentified.
Compared to miR-21 and miR-10a that directly target IL-12 genes, some other miRNAs target signalling components that will cast effects on multiple targets. For example, miR-155 enhanced production of IL-12 by moDCs (O'Connell et al., 2010) ; miR-148/152 suppressed IL-12 production in addition to inhibition of IL-6 production ; miR-23b decreased production of IL-12 while increasing IL-10 production (Zheng et al., 2012) . As introduced above, miR-155 has been found as a positive regulator of IL-12 production by moDCs (O'Connell et al., 2010) .
TNF-α
Although a major task for DCs is to deal with pathogens/microbes, they also respond to self-antigens. Oxidized low-density lipoproteins (oxLDLs) are the risk factor for atherosclerosis and can stimulate a pro-inflammatory response (Chen et al., 2011b) . In this context, it is interesting to note that oxLDLs increased the expression of miR-29a in human moDCs (Chen et al., 2011b) . Manipulation of miR-29a expression established that miR-29a is a negative regulator of TNF-α by oxLDLs-stimulated moDCs (Chen et al., 2011b) . Lipoprotein lipase was identified as a direct target of miR-29a. It remains to be tested whether miR-29a also regulates TNF-α in response to environmental antigens. miRNAs that impact on TNF-α production also include miR-155 (O'Connell et al., 2010) and miR-148/152 .
Although data generated in recent years show that several miRNAs critically regulate the cytokine production by moDCs (mainly from in vitro derived moDCs under GM-CSF) (Table  1) , our understanding on the regulation is still very limited. How miRNAs regulate function of moDCs in vivo has not been examined. Particularly, there is lack of evidence that miRNAs are involved in immunity and immunopathology by regulating the production of cytokine by moDCs. Even for those miRNAs that are important in regulating disease process (O'Connell et al., 2010) , delineation of the in vivo impact of a particular miRNA on different leukocytes remains a challenging task. Furthermore, given that the same miRNA had been shown to have contrast influence on the same lineage of leukocytes (Ceppi et al., 2009; O'Connell et al., 2010) , validation and clarification of current findings in different settings is required before they can serve as the targets for harnessing immune response.
miRNAs REGULATE MATURATION AND ANTIGEN PRESENTATION BY moDCs
Apart from production of cytokines, moDCs also fulfill the role of antigen presentation. Antigen presentation by DCs is critically related to expression of MHC molecules and costimulatory molecules. Evidence presented below illustrates that miRNAs can also impact on maturation of moDCs (Fig. 1) and antigen presentation.
Maturation from monocytes into moDCs
Maturation of moDCs from human monocytes is accompanied with upregulation of DC-SIGN and downregulation of CD14. Based on DC-SIGN/CD14 expression ratios, miR-21, miR-34a, and their cognate targets WNT1 and JAG1 were found to negatively influence moDC differentiation (Hashimi et al., 2009 , Cekaite, 2010 . Similarly, inhibition of miR-511 and miR-99b resulted in reduced DC-SIGN levels (Tserel et al., 2011) . As being a versatile miRNA, miR-155 is also positively involved in maturation of mouse moDCs (Dunand-Sauthier et al., 2011; Lu et al., 2011a) . Transcription factor c-Fos as a target of miR-155 was negatively for moDC maturation (Dunand-Sauthier et al., 2011) . Similarly for what was described for regulation of IL-6 by miR-155 (Ceppi et al., 2009; O'Connell et al., 2010; Dunand-Sauthier et al., 2011) , a positive role for miR-155 in mouse moDC maturation is contrasted by a reported negative role of miR-155 for maturation of human moDC, at least based on DC-Sign expression (Martinez-Nunez et al., 2009) . Maturation from monocytes into moDCs was also found to be correlated with decreased miR-211 (Lu et al., 2011a) . Maturation of human CD14 + moDCs was also found recently to be inhibited by miR-146a .
Costimulatory molecules
LPS and other TLR ligands could induce up-regulation of cell-surface expression of MHCII (I-Ab) and costimulatory molecules (CD80, CD86 and CD40). The up-regulation was attenuated in in vitro-derived moDCs from miR-155-/-mice, leading to reduced antigen presentation and IL-2 production by T cells (Dunand-Sauthier et al., 2011) . Similar to miR-155, low expression of let-7i reduced CD80 and CD86 expression by LPS-stimulated moDCs and SOCS1 acts as a target of let-7i (Zhang et al., 2011) . moDCs with low let-7i expression stimulated low proliferative T-cell response but favored expansion of regulatory T cells (Zhang et al., 2011) .
At some circumstances, DCs express CD40L and costimulate CD8 + T cells via interacting with CD40 on T cells (Johnson et al., 2009 ). Interestingly, miR-146a was found to repress CD40L on human moDCs (Chen et al., 2011a) . Since only certain but not all TLR ligands can strongly stimulate CD40L expression on DCs, it would be interesting to test whether CD146a can be induced preferentially by different TLR ligands.
miRNAs REGULATE EFFECTOR FUNCTION BY moDCs
moDCs are best-known for their production of pro-inflammatory cytokines and ability to induce T cell differentiation. However, they can also acts as effector cells like other myeloid cells. It is noted that certain effector functions are also subjected to regulation by miRNAs. C-type lectin DC-SIGN can mediate binding of certain viral and fungal pathogens (Geijtenbeek et al., 2000; Lanoue et al., 2004) . During LPS-mediated moDC maturation, miR-155 is up-regulated. In cell line with over-expressed miR-155, expression levels of transcription factor PU.1 and DC-SIGN was reduced (Martinez-Nunez et al., 2009 ). Suppression of miR-155 in moDCs increased DC-SIGN expression and improved the binding of HIV protein gp-120 and Candida albicans (Martinez-Nunez et al., 2009) . Similarly, miR-155 has been found to negatively regulate lipid uptake by human moDCs (Chen et al., 2011c) . As miR-155 seems to play a negative role in binding/uptake of antigens, miR-146a in human monocytic cell line showed to increase phagocytosis of Escherichia coli (Pauley et al., 2011) .
miRNAs AFFECT DIFFERENTIATION AND FUNCITON OF OTHER DCs
The main body of current research on the role of miRNAs in regulating DC differentiation and function was with in vitro GM-CSF differentiated DCs. However, several studies have investigated DCs other than moDCs.
Langerhans cells (LCs) are another type of DC that differentiate from monocytes. Relative to monocytes, LCs constitutively express high level of miR-146a (Jurkin et al., 2010) . High miR-146a expression is induced by the transcription factor PU.1 in response to TGF-β1 (Jurkin et al., 2010) . However, forced expression of miR-146a in monocytes does not influence cell differentiation. It remains to be tested whether prevention of miR-146a upregulation during LC differentiation can alter cell fate. At least in mice deficient in miRNA biogenesis by targeting Dicer (Kuipers et al., 2010b) and Drosha in DC lineages (YZ, unpublished) , the pool of LCs was severely diminished. Despite the fact that forced expression of miR-146a does not alter developmental fate, it does reduce TLR2-dependent NFκB signaling (Jurkin et al., 2010) . Conversely, knockdown of miR-146a caused an increase in NFκB signaling (Jurkin et al., 2010) . Thus the authors propose that high constitutive miR-146a levels by LCs make them less susceptible to inappropriate activation by commensal bacteria at the body surfaces.
pDCs are specialized at production of IFN-α (AsselinPaturel et al., 2001; Nakano et al., 2001 ) and express high levels of TLR7 and TLR9 (Edwards et al., 2003) . Study with human pDCs has revealed a fine-balanced role for miR-155 in regulating TLR7-stimulated IFN-α production (Zhou et al., 2010) . Although TLR7 induced up-regulation of both miR-155* and miR-155 through the JNK pathway in pDCs, miR155* induced in the early phase of pDC activation enhanced IFN-α production by suppressing IRAKM, whereas miR-155 upregulated during the later time inhibited their expression by targeting TAB2 (Zhou et al., 2010) . Thus, these two miRNAs cooperatively regulated the production of type-I IFN by human pDCs.
NON-CELL INTRINSIC miRNAs CONTRIBUTE TO REGULATE DC FUNCTION
In the above sections, we discussed how miRNAs expressed by DCs participate in the regulation of differentiation and function of DCs. However, miRNAs can also be secreted to exhibit influence on surrounding cells (Valadi et al., 2007) . Here we summarize a few examples of such non-cell intrinsic functions of secreted miRNAs in the context of DC function.
The first scenario is transfer of miRNA-containing small vesicles (exosomes) from non-DCs to DCs. It has been reported that EBV-transformed lymphoblastoid B cells (LCL) secrete exosomes that contain EBV-miRNAs. The EBVmiRNA containing exosomes are actively internalized by human moDCs. The EBV-miRNA can then suppress the expression of an EBV-targeted gene, chemokine CXCL11, which binds CXCR3 in moDCs (Pegtel et al., 2010) .
The second scenario is transfer of miRNA-containing exosome between DCs (Montecalvo et al., 2012) . In this very recent study, moDCs were found to release miRNA-containing exosomes with maturation-dependent contents. The study also revealed that spontaneous transfer of exosome between DCs occurs in up to 15% of recipient moDCs. Transfer of exosomes between moDCs is an active process since transfer was abrogated in the absence of calcium signalling (Montecalvo et al., 2012) . The functional consequence of transfer of miRNA-containing exosomes between DCs remains to be investigated.
The third scenario is transfer of miRNA-containing exosome from DCs to non DCs. In the aforementioned study (Montecalvo et al., 2012) , miRNA-containing exosome from moDCs can also be transferred into activated CD4 + T cells. In an early study, monocyte-derived miRNA-containing exosome can be transferred into cultured human microvascular endotheliel cells to regulate c-Myb expression and endothelial cell migration (Zhang et al., 2010) .
CONCLUDING REMARK
Rapid progress has been made in recent years in our understanding the role of miRNAs in regulating differentiation and function of DCs. These studies have helped us to better understand the biological significance of these miRNAs. However, notably, most of the current available evidence is derived from in vitro studies with GM-CSF-differentiated DCs, the equivalents of moDCs that become abundant during inflammation/infection (Xu et al., 2007) . It remains to be tested whether these findings from in vitro studies can be applied to in vivo setting when very dynamic interaction between multiple types of immune cells and multiple components of microbes occur. Furthermore, complex DC networks consist of many types of DC subsets with shared and unique functions. It remains largely unknown whether/how miRNAs regulate the function of different DC subsets. Further progress in our understanding of the regulatory role of miRNAs may aid to harness immune responses to maximize beneficial immunity and minimize detrimental immunopathology.
